Company Description
Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide.
It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services.
This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins.
The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services.
Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
| Country | United States |
| Founded | 1932 |
| IPO Date | Nov 3, 1995 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 25,000 |
| CEO | Stanley Bergman |
Contact Details
Address: 135 Duryea Road Melville, New York 11747 United States | |
| Phone | 631 843 5500 |
| Website | henryschein.com |
Stock Details
| Ticker Symbol | HSIC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001000228 |
| CUSIP Number | 806407102 |
| ISIN Number | US8064071025 |
| Employer ID | 11-3136595 |
| SIC Code | 5047 |
Key Executives
| Name | Position |
|---|---|
| Stanley M. Bergman CPA | Executive Chairman and Chief Executive Officer |
| James P. Breslawski CPA | President |
| Ronald N. South | Senior Vice President and Chief Financial Officer |
| Michael Saul Ettinger | Executive Vice President and Chief Operating Officer |
| Mark E. Mlotek | Executive Vice President, Chief Strategic Officer and Executive Director |
| Olga Timoshkina | Vice President of Corporate Finance, Chief Accounting Officer and Corporate Controller |
| Christopher Pendergast | Senior Vice President and Chief Technology Officer |
| Graham Stanley | Vice President of Investor Relations and Strategic Finance Project Officer |
| Walter Siegel | Senior Vice President and Chief Legal Officer |
| Ann Marie Gothard | Vice President of Global Corporate Media Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 13, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Dec 13, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Nov 18, 2024 | 144 | Filing |
| Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 5, 2024 | 10-Q | Quarterly Report |
| Nov 5, 2024 | 8-K | Current Report |
| Oct 8, 2024 | UPLOAD | Filing |
| Sep 27, 2024 | UPLOAD | Filing |
| Sep 6, 2024 | 144 | Filing |